Patent ID: 9480755
Filing Date: 2016-11-01
CPC Classification: A61K,A61P,B82Y

Claim Text:
1. A pharmaceutical composition comprising cyclodextrin and dapagliflozin in the form of an inclusion complex with the molar ratio of cyclodextrin to dapagliflozin being in the range from 1:1 to 2:1, wherein cyclodextrin is selected from the group consisting of β-cyclodextrin, (2-hydroxy)propyl-β-cyclodextrin, randomly methylated-β-cyclodextrin, sulfobutylether-β-cyclodextrin, (2-hydroxy)propyl-γ-cyclodextrin and γ-cyclodextrin; and the entire amount of dapagliflozin is entrapped intercalated into cyclodextrin and the pharmaceutical composition is essentially free of un-entrapped crystalline or amorphous dapagliflozin.